National Health Investors Analyst Ratings
National Health Investors Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/27/2023 | 1.29% | Wells Fargo | $54 → $55 | Maintains | Equal-Weight |
10/03/2023 | -0.55% | Wedbush | → $54 | Initiates Coverage On | → Neutral |
09/28/2023 | — | Berenberg | Initiates Coverage On | → Hold | |
09/20/2023 | -4.24% | Jefferies | → $52 | Initiates Coverage On | → Hold |
05/11/2023 | -0.55% | Wells Fargo | $52 → $54 | Maintains | Equal-Weight |
03/29/2023 | -7.92% | Credit Suisse | $55 → $50 | Maintains | Neutral |
12/09/2022 | 6.81% | Credit Suisse | $47 → $58 | Upgrades | Underperform → Neutral |
09/26/2022 | 12.34% | Truist Securities | $64 → $61 | Maintains | Hold |
06/21/2022 | 14.18% | BMO Capital | → $62 | Downgrades | Outperform → Market Perform |
04/19/2022 | 12.34% | BMO Capital | $63 → $61 | Maintains | Outperform |
02/01/2022 | -6.08% | Credit Suisse | → $51 | Initiates Coverage On | → Underperform |
01/07/2022 | 25.23% | BMO Capital | → $68 | Upgrades | Market Perform → Outperform |
07/23/2021 | 32.6% | Wells Fargo | $74 → $72 | Maintains | Equal-Weight |
06/18/2021 | 30.76% | BMO Capital | → $71 | Upgrades | Underperform → Market Perform |
03/30/2021 | 41.8% | Capital One | → $77 | Downgrades | Overweight → Equal-Weight |
01/13/2021 | 1.29% | Mizuho | → $55 | Downgrades | Neutral → Underperform |
01/08/2021 | — | BMO Capital | Downgrades | Market Perform → Underperform | |
12/14/2020 | — | Keybanc | Upgrades | Underweight → Sector Weight | |
09/02/2020 | 16.02% | Stifel | → $63 | Reinstates | → Hold |
06/24/2020 | 17.86% | SunTrust Robinson Humphrey | $61 → $64 | Maintains | Hold |
06/17/2020 | 21.55% | Wells Fargo | $54 → $66 | Maintains | Equal-Weight |
06/08/2020 | — | JMP Securities | Reinstates | → Market Perform | |
05/22/2020 | 1.29% | Mizuho | $60 → $55 | Downgrades | Buy → Neutral |
05/14/2020 | -26.34% | Keybanc | $43 → $40 | Maintains | Underweight |
04/23/2020 | 12.34% | SunTrust Robinson Humphrey | $77 → $61 | Maintains | Hold |
04/21/2020 | -20.81% | Keybanc | $65 → $43 | Maintains | Underweight |
03/26/2020 | -6.08% | Wells Fargo | $82 → $51 | Maintains | Equal-Weight |
02/05/2020 | — | Berenberg | Initiates Coverage On | → Buy | |
01/07/2020 | 51.01% | BMO Capital | → $82 | Upgrades | Underperform → Market Perform |
12/20/2019 | 74.95% | Mizuho | → $95 | Assumes | → Buy |
02/20/2019 | — | BMO Capital | Downgrades | Market Perform → Underperform |
日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
---|---|---|---|---|---|
11/27/2023 | 1.29% | 富国银行 | 54 美元 → 55 美元 | 维护 | 重量相等 |
2023 年 3 月 10 日 | -0.55% | Wedbush | → 54 美元 | 启动覆盖范围开启 | → 中立 |
09/28/2023 | — | 贝伦贝格 | 启动覆盖范围开启 | → 按住 | |
09/20/2023 | -4.24% | 杰富瑞集团 | → 52 美元 | 启动覆盖范围开启 | → 按住 |
05/11/2023 | -0.55% | 富国银行 | 52 美元 → 54 美元 | 维护 | 重量相等 |
03/29/2023 | -7.92% | 瑞士信贷 | 55 美元 → 50 美元 | 维护 | 中立 |
2022 年 9 月 12 日 | 6.81% | 瑞士信贷 | 47 美元 → 58 美元 | 升级 | 表现不佳 → 中性 |
09/26/2022 | 12.34% | Truist 证券 | 64 美元 → 61 美元 | 维护 | 保持 |
2022 年 6 月 21 日 | 14.18% | BMO Capital | → 62 美元 | 降级 | 跑赢大盘 → 市场表现 |
04/19/2022 | 12.34% | BMO Capital | 63 美元 → 61 美元 | 维护 | 跑赢大盘 |
2022 年 1 月 2 日 | -6.08% | 瑞士信贷 | → 51 美元 | 启动覆盖范围开启 | → 表现不佳 |
2022 年 7 月 1 日 | 25.23% | BMO Capital | → 68 美元 | 升级 | 市场表现 → 跑赢大盘 |
2021 年 7 月 23 日 | 32.6% | 富国银行 | 74 美元 → 72 美元 | 维护 | 重量相等 |
06/18/2021 | 30.76% | BMO Capital | → 71 美元 | 升级 | 表现不佳 → 市场表现 |
03/30/2021 | 41.8% | 第一资本 | → 77 美元 | 降级 | 超重 → 重量相等 |
2021 年 1 月 13 日 | 1.29% | 瑞穗市 | → 55 美元 | 降级 | 中性 → 跑赢大盘 |
01/08/2021 | — | BMO Capital | 降级 | 市场表现 → 表现不佳 | |
2020 年 12 月 14 日 | — | Keybanc | 升级 | 减持 → 行业权重 | |
2020 年 2 月 9 日 | 16.02% | Stifel | → 63 美元 | 恢复 | → 按住 |
06/24/2020 | 17.86% | SunTrust 罗宾逊·汉弗莱 | 61 美元 → 64 美元 | 维护 | 保持 |
2020 年 6 月 17 日 | 21.55% | 富国银行 | 54 美元 → 66 美元 | 维护 | 重量相等 |
06/08/2020 | — | JMP 证券 | 恢复 | → 市场表现 | |
05/22/2020 | 1.29% | 瑞穗市 | 60 美元 → 55 美元 | 降级 | 买入 → 中性 |
05/14/2020 | -26.34% | Keybanc | 43 美元 → 40 美元 | 维护 | 体重不足 |
04/23/2020 | 12.34% | SunTrust 罗宾逊·汉弗莱 | 77 美元 → 61 美元 | 维护 | 保持 |
2020 年 4 月 21 日 | -20.81% | Keybanc | 65 美元 → 43 美元 | 维护 | 体重不足 |
2020 年 3 月 26 日 | -6.08% | 富国银行 | 82 美元 → 51 美元 | 维护 | 重量相等 |
02/05/2020 | — | 贝伦贝格 | 启动覆盖范围开启 | → 购买 | |
01/07/2020 | 51.01% | BMO Capital | → 82 美元 | 升级 | 表现不佳 → 市场表现 |
12/20/2019 | 74.95% | 瑞穗市 | → 95 美元 | 假设 | → 购买 |
02/20/2019 | — | BMO Capital | 降级 | 市场表现 → 表现不佳 |
What is the target price for National Health Investors (NHI)?
国民健康投资者(NHI)的目标价格是多少?
The latest price target for National Health Investors (NYSE: NHI) was reported by Wells Fargo on November 27, 2023. The analyst firm set a price target for $55.00 expecting NHI to rise to within 12 months (a possible 1.29% upside). 7 analyst firms have reported ratings in the last year.
富国银行于2023年11月27日公布了国家健康投资者(纽约证券交易所代码:NHI)的最新目标股价。该分析公司将目标股价定为55.00美元,预计NHI将在12个月内升至12个月内(可能上涨1.29%)。去年有7家分析公司公布了评级。
What is the most recent analyst rating for National Health Investors (NHI)?
国家健康投资者(NHI)的最新分析师评级是多少?
The latest analyst rating for National Health Investors (NYSE: NHI) was provided by Wells Fargo, and National Health Investors maintained their equal-weight rating.
富国银行对National Health Investors(纽约证券交易所代码:NHI)的最新分析师评级由富国银行提供,国民健康投资者维持同等权重评级。
When is the next analyst rating going to be posted or updated for National Health Investors (NHI)?
国家健康投资者(NHI)的下一次分析师评级何时公布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of National Health Investors, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for National Health Investors was filed on November 27, 2023 so you should expect the next rating to be made available sometime around November 27, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括浏览公开财务报表,与National Health Investors的高管和客户交谈,以及听取财报电话会议。大多数分析师每三个月做一次这样的评级,因此每家公司每年应该获得4次评级。National Health Investors的最新评级是在2023年11月27日公布的,因此您应该预计下一个评级将在2024年11月27日左右公布。
Is the Analyst Rating National Health Investors (NHI) correct?
分析师对国民健康投资者(NHI)的评级是否正确?
While ratings are subjective and will change, the latest National Health Investors (NHI) rating was a maintained with a price target of $54.00 to $55.00. The current price National Health Investors (NHI) is trading at is $54.30, which is within the analyst's predicted range.
尽管评级是主观的,并且会发生变化,但最新的国家健康投资者(NHI)评级维持不变,目标股价为54.00美元至55.00美元。国家健康投资者(NHI)目前的交易价格为54.30美元,在分析师的预测区间内。